NFKB1 and Fulminant hepatitis: Taken together, these results suggest that Fuc-S-α-CDE (G2, DSC1, DSF2) has the potential for a novel Kupffer cell-selective NF-κB decoy carrier for the treatment of LPS-induced fulminant hepatitis in mice [72,73].